SB 357 Maryland Senate · 2025 Regular Session

Prescription Drug Affordability Board - Authority and Stakeholder Council Membership (Lowering Prescription Drug Costs for All Marylanders Now Act)

SB 357 creates a process for Maryland's Prescription Drug Affordability Board to set price limits ("upper payment limits") on prescription drugs causing affordability challenges for Marylanders. The Board must consider costs like administration and delivery when setting limits, and must reconsider or suspend limits if a drug faces a shortage (defined as appearing on the federal shortage list or determined by the Board). The bill prohibits applying these limits to drugs on federal shortage lists, Medicare Part C/D reimbursements, or pharmacy dispensing fees. This directly affects all Maryland residents using prescription drugs, insurers, and health plans through changes to how drug costs are managed in the state.
Bill status signed all 5 stages cleared
Introduction
Jan 2025
Committee Review
Apr 2025
Senate Passage
Apr 2025
House of Delegates Passage
Apr 2025
Signed into Law
May 2025
Introduced Jan 16, 2025 Signed May 20, 2025
Maddy AI version diff · 2 comparisons

What changed between versions

Third - Prescription Drug Affordability Board - Authority and Stakeholder Council Membership (Lowering Prescription Drug Costs for All Marylanders Now Act) Enrolled - Prescription Drug Affordability Board - Authority and Stakeholder Council Membership (Lowering Prescription Drug Costs for All Marylanders Now Act) · 3 edits · May 20, 2025
MINOR
The bill was finalized into an enrolled version, changing its status from a draft Senate bill to a law ready for the Governor's signature. The substantive policy content regarding the Prescription Drug Affordability Board and Stakeholder Council remains unchanged, but the formatting was standardized to reflect official legislative enactment.
TECHNICAL

The document format was updated from a draft Senate Bill to an Enrolled Bill, including the addition of proofreader signatures and the Governor's approval block.

The explanatory notes regarding how to read the bill text were updated to include italics for opposite chamber or conference committee amendments.

The bill's preamble and section headers were reorganized to align with the standard format for enrolled legislation in Maryland.

Floor votes · Senate Mar 23, 2025 · House of Delegates Mar 23, 2025

How they voted

3111
Passed · 4 other
Total votes 46
Mar 23, 2025
D Democratic33
30 Yea 3
90% Yea
R Republican13
1 Yea 11 Nay 1
84% Nay
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
19
Key actions
11
Committee
7
Amendments
2
May 20, 2025
Signed into law
Approved by the Governor - Chapter 610
executive
Apr 7, 2025
Upper · Passed
Passed Enrolled
upper
Apr 7, 2025
Introduced
Senate Concurs House Amendments
upper
Apr 7, 2025
Lower · Passed
Third Reading Passed
lower
Apr 1, 2025
Lower · Passed
Favorable with Amendments {
lower
Apr 1, 2025
Lower · Passed
Favorable with Amendments Report by Health and Government Operations
lower
Mar 23, 2025
Senate · Passed
Senate Vote: pass (31-11-4)
senate
Mar 13, 2025
Committee
Referred Health and Government Operations
lower
Mar 12, 2025
Upper · Passed
Third Reading Passed
upper
Mar 12, 2025
Introduced
Floor Amendment {
upper
Mar 12, 2025
Upper · Passed
Committee Amendment {
upper
Mar 11, 2025
Upper · Passed
Motion Laid Over (Senator Salling) Adopted
upper
Mar 11, 2025
Upper · Passed
Favorable with Amendments {
upper
Mar 10, 2025
Upper · Passed
Favorable with Amendments Report by Finance
upper
Jan 16, 2025
Committee
First Reading Finance
upper
3 primary · 0 co-sponsors

Sponsors